Myotonic dystrophy type 2: systemic features
Evidence-based neurology checklist on myotonic dystrophy type 2: systemic features: Dermatological features Frontal balding Hyperhidrosis Dysplastic nevi Xerosis Seborrheic dermatitis Premature aging Cardiac features Gastrointestinal features Metabolic features Associated autoimmune disorders: in…
Dermatological features
- Frontal balding
- Hyperhidrosis
- Dysplastic nevi
- Xerosis
- Seborrheic dermatitis
- Premature aging
Cardiac features
Gastrointestinal features
Metabolic features
Associated autoimmune disorders: in 20-30% of cases
Other features
References
- Meola G. Myotonic dystrophy type 2: the 2020 update. Acta Myol 2020; 39:222-234.
- Meola G, Cardani R. Myotonic dystrophy type 2: an update on clinical aspects, genetic and pathomolecular mechanism. J Neuromuscul Dis 2015; 2(s2):S59-S71.
- Day JW, Ricker K, Jacobsen JF, et al. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 2003; 60:657-664.
- Finsterer J. Myotonic dystrophy type 2. Eur J Neurol 2002; 9:441-447.
- Bertorini TE. Neuromuscular Case studies. Butterworth Heinemann Philadelphia 2008 pp618-619.
- And 8 more. Subscribe to see the full list
